RPS6KB1 and melanoma: eEF2K is activated by β2-AR/PKA signaling in cardiomyocytes and melanoma cells21,84 and by the inhibition of mTORC1/p70S6K cascade82,83, the latter also responsive to β2-AR/Gαs/adenylyl cyclase/PKA signaling.